July 24, 2018
On June 15, the European Chemicals Agency (ECHA) announced that its Risk Assessment Committee (RAC) adopted opinions on harmonized classification and labeling of 13 substances. Amongst others, RAC agreed to classify MBIT (2-methyl-1,2-benzisothiazol3(2H)-one) as a substance that may cause an allergic skin reaction (Skin Sens. 1A), with a specific concentration limit (SCL) of 15 ppm.
MBIT has recently been approved as a new active substance for use in biocidal products for product-type 6 (preservatives for products during storage) under the BPR.
Dow Microbial Control strongly contests the basis of the decision for an SCL of 15 ppm for skin sensitization, since the available data clearly supports the use of the generic concentration limit (GCL) of 1000 ppm. Dow Microbial Control is currently evaluating options for the continued defense of MBIT as an effective preservative under the BPR.
Dow Microbial Control is fully committed to supporting its biocidal products and the needs of our customers. For further support on biocidal compliance, please contact your local sales representative, contact us for more information or refer to our BPR checklist.
BPC supports approval of DBNPA for PT4
August 2, 2018
UK submits CLH proposal for Phenoxyethanol
July 26, 2018
Check if you and your biocide suppliers are ready for BPR. Download the BPR Checklist
Do you have any questions or need further assistance? Contact us to get your questions on BPR answered.
Copyright © The Dow Chemical Company (1995-2014). All Rights Reserved.
®™* Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow